Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $130.30 | 6 | 77.4% |
| Debt forgiveness | $38.06 | 1 | 22.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $73.73 | 4 | $0 (2024) |
| Welch Allyn | $38.06 | 1 | $0 (2021) |
| LINUS HEALTH, INC. | $35.81 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $20.76 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.84 | 4 | PFIZER INC. ($53.08) |
| 2023 | $56.46 | 2 | LINUS HEALTH, INC. ($35.81) |
| 2021 | $38.06 | 1 | Welch Allyn ($38.06) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: VACCINE | ||||||
| 05/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/02/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2023 | LINUS HEALTH, INC. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $35.81 | General |
| Category: DEVICE | ||||||
| 09/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/23/2021 | Welch Allyn | None (Device) | Debt forgiveness | Cash or cash equivalent | $38.06 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,388 | 1,707 | $372,452 | $119,246 |
| 2022 | 12 | 1,395 | 1,736 | $367,520 | $121,639 |
| 2021 | 14 | 1,420 | 1,772 | $364,785 | $122,844 |
| 2020 | 11 | 1,277 | 1,577 | $307,895 | $92,910 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 259 | 259 | $80,290 | $36,734 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 448 | $121,672 | $30,273 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 245 | $93,405 | $23,577 | 25.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 160 | 160 | $25,920 | $11,509 | 44.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 161 | 161 | $14,490 | $5,448 | 37.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,130 | $5,027 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 224 | 248 | $18,600 | $2,628 | 14.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,400 | $2,168 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 17 | $2,925 | $757.09 | 25.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $1,620 | $609.12 | 37.6% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 120 | 120 | $3,000 | $514.80 | 17.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 245 | 245 | $75,950 | $35,761 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 215 | 446 | $117,025 | $31,319 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 248 | $90,475 | $22,921 | 25.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 168 | 169 | $26,095 | $11,570 | 44.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $6,210 | $6,102 | 98.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 171 | 172 | $15,560 | $5,796 | 37.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $9,000 | $3,706 | 41.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 215 | 239 | $17,925 | $2,353 | 13.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 25 | 25 | $2,670 | $848.24 | 31.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 14 | $2,335 | $616.76 | 26.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 117 | 117 | $2,925 | $506.08 | 17.3% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2022 | 18 | 18 | $1,350 | $141.19 | 10.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 221 | 401 | $133,135 | $41,111 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 225 | 225 | $69,750 | $33,482 | 48.0% |
About Dr. William Holgerson, MD
Dr. William Holgerson, MD is a Internal Medicine healthcare provider based in Wellesley, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356445829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Holgerson, MD has received a total of $168.36 in payments from pharmaceutical and medical device companies, with $73.84 received in 2024. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($130.30).
As a Medicare-enrolled provider, Holgerson has provided services to 5,480 Medicare beneficiaries, totaling 6,792 services with total Medicare billing of $456,639. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wellesley, MA
- Active Since 09/12/2006
- Last Updated 06/26/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356445829
Products in Payments
- ELIQUIS (Drug) $73.73
- None (Device) $38.06
- CORE COGNITIVE EVALUATION (Device) $35.81
- GARDASIL (Biological) $20.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wellesley
Dr. Dianne Quibell, M.d, M.D
Internal Medicine — Payments: $64,930
David Schroeder, Md, MD
Internal Medicine — Payments: $4,405
Christine Harrington, M.d, M.D
Internal Medicine — Payments: $3,039
Dr. Alan Glaser, Md, MD
Internal Medicine — Payments: $1,194
Ikram Farooqi, M.d. C.w.s, M.D. C.W.S
Internal Medicine — Payments: $719.04
Dr. Li Tso, M.d, M.D
Internal Medicine — Payments: $322.83